Correlation Between 23Andme Holding and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on 23Andme Holding and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Sonnet Biotherapeutics.
Diversification Opportunities for 23Andme Holding and Sonnet Biotherapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between 23Andme and Sonnet is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Sonnet Biotherapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to generate 1.83 times more return on investment than Sonnet Biotherapeutics. However, 23Andme Holding is 1.83 times more volatile than Sonnet Biotherapeutics Holdings. It trades about -0.22 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.54 per unit of risk. If you would invest 494.00 in 23Andme Holding Co on August 30, 2024 and sell it today you would lose (180.00) from holding 23Andme Holding Co or give up 36.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| 23Andme Holding |
| Sonnet Biotherapeutics |
23Andme Holding and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Sonnet Biotherapeutics
The main advantage of trading using opposite 23Andme Holding and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Sonnet Biotherapeutics vs. Ikena Oncology | Sonnet Biotherapeutics vs. Eliem Therapeutics | Sonnet Biotherapeutics vs. HCW Biologics | Sonnet Biotherapeutics vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |